FRONTEO has Constructed a Pathway Map of the Coronavirus Infection (COVID-19) to be Published for Use in Therapeutic Drug Selection and Review
FRONTEO Commences Drug Repositioning Research on Novel Coronavirus (COVID-19) Using Best-In-Class AI
April 17, 2020FRONTEO Has Identified 450 Candidate Compounds In Its Research On The Novel Coronavirus (COVID-19)
May 6, 2020NEW YORK, April 30, 2020 – FRONTEO (TSE: 2158) FRONTEO has announced the successful creation of a pathway map for the novel coronavirus infection (COVID-19), using its proprietary AI system “Cascade Eye”.
The pathway map visually identifies crucial molecules, genes, and drug candidates in relation to COVID-19.
FRONTEO’s AI-powered drug discovery support tool “Cascade Eye” was able to analyze research about the genes and molecules to create a pathway map, making it possible to search for existing drug candidates to combat COVID-19.
“Cascade Eye” is powered by Concept Encoder (conceptencoder®), FRONTEO’s proprietary natural language processing AI engine, which analyzes molecular, genetic, and other information related to various diseases in a fraction of the time it takes humans, and is capable of visualizing this information in the form of a pathway map.
“Cascade Eye” was able to identify key molecules in COVID-19 that are targets of existing drugs to create a pathway map, unhindered by human prejudice or bias.
In addition to discovering new targets and biomarkers that may be overlooked because of human bias, it can also help predict the efficacy and safety of treatments using existing drugs. FRONTEO plans to publish the COVID-19 pathway map and make it widely available to both pharmaceutical companies and public institutions to aid in therapeutic drug selection and review
FRONTEO plans to publish the COVID-19 pathway map and make it widely available to both pharmaceutical companies and public institutions to aid in therapeutic drug selection and review.
About FRONTEO. Everything we do comes from our service-oriented culture that puts the client at its center. We develop and constantly improve leading-edge technology. And we market custom, seamless services that create value for our clients, employees, consumers and shareholders. Our name is no coincidence. “FRONTEO” helps us focus while looking forward, empowering us to apply our AI technology to the mission-critical legal market. We combine our machine learning with unparalleled attention to our clients. At FRONTEO, you are the center of our universe. You define your needs, and we are your helpmates and facilitators. Together, now and in the future, we succeed.
For more information about FRONTEO, contact usinfo@fronteo.com or visit https://www.fronteousa.com/usa/
